| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_FBXW7_0003100 | Exon-Exon | chr4:153253748-153268223 | chr4:152332596-152347071 | 266 nt | 0.4925 |
| hsa_FBXW7_0003200 | Exon-Exon | chr4:153253748-153271276 | chr4:152332596-152350124 | 360 nt | 0.4444 |
| hsa_FBXW7_0002900 | Exon-Exon | chr4:153253748-153333024 | chr4:152332596-152411872 | 1054 nt | 0.4526 |
| hsa_chr4_0190300 | Intergenic-Intergenic | chr4:153256266-153256647 | chr4:152335114-152335495 | 382 nt | 0.4581 |
| hsa_FBXW7_0003300 | Intron-Exon-Intron | chr4:153256793-153259088 | chr4:152335641-152337936 | 2296 nt | 0.2940 |
| hsa_FBXW7_0003400 | Exon-Exon | chr4:153258954-153271264 | chr4:152337802-152350112 | 348 nt | 0.4511 |
| hsa_FBXW7_0003500 | Exon-Exon | chr4:153258954-153271276 | chr4:152337802-152350124 | 360 nt | 0.4444 |
| hsa_FBXW7_0003600 | Exon-Exon | chr4:153258954-153333024 | chr4:152337802-152411872 | 135 nt | 0.4000 |
| hsa_FBXW7_0003700 | Exon-Exon | chr4:153258954-153333681 | chr4:152337802-152412529 | 56 nt | 0.4464 |
| hsa_chr4_0190400 | Intergenic-Intergenic | chr4:153266257-153267092 | chr4:152345105-152345940 | 836 nt | 0.3254 |
A study in human brain cancer demonstrated that the circFBXW7 functions as a tumor suppressor, where its expression inhibits cell progression, migration, and tumor formation [Di Agostino et al. DOI:10.3389/fcell.2020.00389]. Further research confirmed its coding potential, showing the translated peptide FBXW7-185aa reduces the half-life of c-Myc and inhibits cell cycle progression [Sema Misir et al. DOI:10.1038/s41418-022-00948-7]. The peptide FBXW7-185aa, which originates from the circFBXW7, inhibits cell cycle progression [Misir et al. DOI:10.1038/s41418-022-00948-7].